Status:

UNKNOWN

Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis

Lead Sponsor:

Azidus Brasil

Conditions:

Bacterial Conjunctivitis

Acute

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The primary objective of this study is to evaluate, through clinical parameters, the effectiveness of your medicine topic Maxinom ® (dexamethasone, neomycin and polymyxin B - Union Chemicals), compari...

Detailed Description

1. Evaluation of isolated signs and symptoms during treatment, with a record of individual scores for each parameter and observation 2. Statistical comparison of drug safety, by recording qualitative ...

Eligibility Criteria

Inclusion

  • Patients who agree with all study procedures and sign, by his own free will, IC;
  • Adult patients, regardless of gender, ethnicity or social status, with good mental health;
  • Patients who present at screening visit, picture of acute bacterial conjunctivitis diagnosed clinically.

Exclusion

  • Patients with clinical diagnosis or suspicion of conjunctivitis due to any process that is not due to bacterial infection, such as infections by fungi, protozoa, viruses and allergic conjunctivitis;
  • Patients with known hypersensitivity to any component of the formulas of the study drugs;
  • Patients with a history or clinical diagnosis of other lesions that may affect the outcome, such as glaucoma, corneal ulcer or scars;
  • Concomitant use of ocular medication other than the study;
  • Pregnant or lactating women;
  • Being or having been treated for any type of conjunctivitis within 15 days and have finished treatment or less than 07 days

Key Trial Info

Start Date :

February 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT01227863

Start Date

February 1 2011

Last Update

October 25 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

LAL Clinica Pesquisa e Desenvolvimento Ltda

Valinhos, São Paulo, Brazil